John Hamer
QuietNamed in filings at DCVC
- Board seats filed
- 9
all filings on record
Named in filings at DCVC
all filings on record
last 24 months
from a verified or cited source
| Avicenna Biosciences | Biotech & pharma | February 2022 | None on file |
| Umoja Biopharma | Biotech & pharma | June 2021 | MPM BioVentures |
| Unlearn.ai | Biotech & pharma | April 2020 | None on file |
| Empirico | Biotech & pharma | November 2018 | None on file |
| AbCellera Biologics | Biotech & pharma | August 2018 | None on file |
| Pivot Bio | Food & agriculture | January 2016 | None on file |
| WELLPARTNER | Healthcare services | February 2012 | None on file |
| OLEDWorks | Manufacturing & industrials | November 2011 | None on file |
| CHROMATIN | Food & agriculture | October 2011 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name John Hamer on the board, based on 9 filed seats with a verified or cited source.